Literature DB >> 17101217

Inhibition of neuronal nitric oxide synthase antagonizes morphine antinociceptive tolerance by decreasing activation of p38 MAPK in the spinal microglia.

Wei Liu1, Chu-Huai Wang, Yu Cui, Li-Qiu Mo, Jun-Li Zhi, Sheng-Nan Sun, Yan-Li Wang, Hui-Min Yu, Chun-Mei Zhao, Jian-Qiang Feng, Pei-Xi Chen.   

Abstract

We have demonstrated that the activation of p38 mitogen-activated protein kinase (MAPK) in the spinal microglia played an essential role in the development of morphine antinociceptive tolerance. The aim of this study was to investigate whether inhibition of neuronal nitric oxide synthase (nNOS) attenuated tolerance to morphine analgesia by modulating p38 activation in the spinal microglia. It was shown that the selective inhibitor of nNOS, 7-NINA (7-Nitroindazole, sodium salt) (25 microg, i.t.) attenuated not only the development of morphine antinociceptive tolerance, but also the activation of p38 MAPK in the spinal microglia induced by chronic intrathecal administration of morphine. Our results suggest that neuronal NO signals to microglia, leading to the upregulation of microglial phospho-p38 MAPK. Such p38 MAPK activation in microglia is consistent with a potential role in the development of morphine antinociceptive tolerance. We demonstrated for the first time that the inhibition of nNOS attenuated morphine antinociceptive tolerance by reducing p38 MAPK activation in the spinal microglia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101217     DOI: 10.1016/j.neulet.2006.08.091

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  22 in total

Review 1.  Opioid-induced central immune signaling: implications for opioid analgesia.

Authors:  Peter M Grace; Steven F Maier; Linda R Watkins
Journal:  Headache       Date:  2015-03-31       Impact factor: 5.887

Review 2.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

Review 3.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 4.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

Review 5.  The role of mitogen-activated protein kinase (MAPK) in morphine tolerance and dependence.

Authors:  Yong Chen; Claudia Sommer
Journal:  Mol Neurobiol       Date:  2009-05-26       Impact factor: 5.590

6.  Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists.

Authors:  Ahmet Altun; Kemal Yildirim; Ercan Ozdemir; Ihsan Bagcivan; Sinan Gursoy; Nedim Durmus
Journal:  J Physiol Sci       Date:  2015-04-18       Impact factor: 2.781

7.  Attenuation of morphine analgesic tolerance by rosuvastatin in naïve and morphine tolerance rats.

Authors:  Yongle Li; Yinyin Shu; Qing Ji; Jian Liu; Xiaoyun He; Weiyan Li
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

8.  Morphine tolerance is attenuated in germfree mice and reversed by probiotics, implicating the role of gut microbiome.

Authors:  Li Zhang; Jingjing Meng; Yuguang Ban; Richa Jalodia; Irina Chupikova; Irina Fernandez; Nivis Brito; Umakant Sharma; Maria T Abreu; Sundaram Ramakrishnan; Sabita Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-17       Impact factor: 11.205

9.  Phosphorylated neuronal nitric oxide synthase in neuropathic pain in rats.

Authors:  Zhidong Zhou; Yingping Liang; Fumou Deng; Yong Cheng; Jing Sun; Lian Guo; Guohai Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

10.  Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).

Authors:  Mark R Hutchinson; Yingning Zhang; Kimberley Brown; Benjamen D Coats; Mitesh Shridhar; Paige W Sholar; Sonica J Patel; Nicole Y Crysdale; Jacqueline A Harrison; Steven F Maier; Kenner C Rice; Linda R Watkins
Journal:  Eur J Neurosci       Date:  2008-07       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.